nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—SCN10A—skin cancer	0.823	1	CbGaD
Lacosamide—CA6—ear—skin cancer	0.00825	0.142	CbGeAlD
Lacosamide—CA3—ear—skin cancer	0.00781	0.135	CbGeAlD
Lacosamide—CA6—hair follicle—skin cancer	0.00435	0.0749	CbGeAlD
Lacosamide—SCN10A—nerve—skin cancer	0.00333	0.0574	CbGeAlD
Lacosamide—CA1—nerve—skin cancer	0.00276	0.0475	CbGeAlD
Lacosamide—CA4—nerve—skin cancer	0.00216	0.0371	CbGeAlD
Lacosamide—CA3—connective tissue—skin cancer	0.00198	0.0341	CbGeAlD
Lacosamide—CA2—hair follicle—skin cancer	0.0015	0.0258	CbGeAlD
Lacosamide—CA9—female reproductive system—skin cancer	0.00134	0.023	CbGeAlD
Lacosamide—CA6—head—skin cancer	0.00123	0.0212	CbGeAlD
Lacosamide—CA4—nipple—skin cancer	0.00122	0.0211	CbGeAlD
Lacosamide—CA4—neck—skin cancer	0.00121	0.0209	CbGeAlD
Lacosamide—CA3—head—skin cancer	0.00117	0.0201	CbGeAlD
Lacosamide—CA5B—mammalian vulva—skin cancer	0.00104	0.0178	CbGeAlD
Lacosamide—CA2—nipple—skin cancer	0.00102	0.0175	CbGeAlD
Lacosamide—CA2—neck—skin cancer	0.001	0.0173	CbGeAlD
Lacosamide—SCN10A—lymphoid tissue—skin cancer	0.000981	0.0169	CbGeAlD
Lacosamide—Nervous system disorder—Vismodegib—skin cancer	0.000939	0.00787	CcSEcCtD
Lacosamide—Skin disorder—Vismodegib—skin cancer	0.00093	0.0078	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.000919	0.00771	CcSEcCtD
Lacosamide—CA5B—female reproductive system—skin cancer	0.000887	0.0153	CbGeAlD
Lacosamide—Gait disturbance—Temozolomide—skin cancer	0.000868	0.00728	CcSEcCtD
Lacosamide—Coordination abnormal—Temozolomide—skin cancer	0.000863	0.00723	CcSEcCtD
Lacosamide—SCN3A—female reproductive system—skin cancer	0.000862	0.0149	CbGeAlD
Lacosamide—Dyspepsia—Vismodegib—skin cancer	0.000843	0.00707	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Vismodegib—skin cancer	0.000827	0.00693	CcSEcCtD
Lacosamide—Fatigue—Vismodegib—skin cancer	0.000825	0.00692	CcSEcCtD
Lacosamide—Dysarthria—Fluorouracil—skin cancer	0.000825	0.00692	CcSEcCtD
Lacosamide—Constipation—Vismodegib—skin cancer	0.000819	0.00686	CcSEcCtD
Lacosamide—Connective tissue disorder—Vemurafenib—skin cancer	0.000818	0.00686	CcSEcCtD
Lacosamide—CA3—lymph node—skin cancer	0.000817	0.0141	CbGeAlD
Lacosamide—CA1—lymphoid tissue—skin cancer	0.000812	0.014	CbGeAlD
Lacosamide—SCN10A—head—skin cancer	0.00079	0.0136	CbGeAlD
Lacosamide—Depression—Imiquimod—skin cancer	0.000789	0.00661	CcSEcCtD
Lacosamide—Erythema multiforme—Vemurafenib—skin cancer	0.000787	0.0066	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.000784	0.00657	CcSEcCtD
Lacosamide—CA1—female reproductive system—skin cancer	0.000784	0.0135	CbGeAlD
Lacosamide—Eye disorder—Vemurafenib—skin cancer	0.000778	0.00652	CcSEcCtD
Lacosamide—Cardiac disorder—Vemurafenib—skin cancer	0.000773	0.00648	CcSEcCtD
Lacosamide—Hepatobiliary disease—Imiquimod—skin cancer	0.000748	0.00627	CcSEcCtD
Lacosamide—CA5B—head—skin cancer	0.000741	0.0128	CbGeAlD
Lacosamide—SCN9A—lymph node—skin cancer	0.000727	0.0125	CbGeAlD
Lacosamide—Erythema—Vemurafenib—skin cancer	0.000725	0.00608	CcSEcCtD
Lacosamide—SCN3A—head—skin cancer	0.00072	0.0124	CbGeAlD
Lacosamide—CA2—connective tissue—skin cancer	0.00072	0.0124	CbGeAlD
Lacosamide—Connective tissue disorder—Imiquimod—skin cancer	0.000698	0.00585	CcSEcCtD
Lacosamide—Asthenia—Vismodegib—skin cancer	0.000687	0.00576	CcSEcCtD
Lacosamide—CA2—epithelium—skin cancer	0.000684	0.0118	CbGeAlD
Lacosamide—Pruritus—Vismodegib—skin cancer	0.000677	0.00568	CcSEcCtD
Lacosamide—Erythema multiforme—Imiquimod—skin cancer	0.000671	0.00563	CcSEcCtD
Lacosamide—Euphoric mood—Fluorouracil—skin cancer	0.000671	0.00562	CcSEcCtD
Lacosamide—Eye disorder—Imiquimod—skin cancer	0.000663	0.00556	CcSEcCtD
Lacosamide—Tinnitus—Imiquimod—skin cancer	0.000662	0.00555	CcSEcCtD
Lacosamide—Diarrhoea—Vismodegib—skin cancer	0.000655	0.00549	CcSEcCtD
Lacosamide—CA1—head—skin cancer	0.000655	0.0113	CbGeAlD
Lacosamide—CA2—skin of body—skin cancer	0.00065	0.0112	CbGeAlD
Lacosamide—Immune system disorder—Imiquimod—skin cancer	0.000641	0.00538	CcSEcCtD
Lacosamide—Liver function test abnormal—Dactinomycin—skin cancer	0.000628	0.00526	CcSEcCtD
Lacosamide—Mental disorder—Imiquimod—skin cancer	0.000622	0.00522	CcSEcCtD
Lacosamide—Erythema—Imiquimod—skin cancer	0.000618	0.00518	CcSEcCtD
Lacosamide—Diplopia—Temozolomide—skin cancer	0.000615	0.00516	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000613	0.00514	CcSEcCtD
Lacosamide—CA4—female reproductive system—skin cancer	0.000613	0.0105	CbGeAlD
Lacosamide—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000612	0.00513	CcSEcCtD
Lacosamide—Vomiting—Vismodegib—skin cancer	0.000609	0.0051	CcSEcCtD
Lacosamide—Affect lability—Temozolomide—skin cancer	0.000605	0.00508	CcSEcCtD
Lacosamide—Rash—Vismodegib—skin cancer	0.000604	0.00506	CcSEcCtD
Lacosamide—Dermatitis—Vismodegib—skin cancer	0.000603	0.00506	CcSEcCtD
Lacosamide—CA2—mammalian vulva—skin cancer	0.000593	0.0102	CbGeAlD
Lacosamide—Mood swings—Temozolomide—skin cancer	0.000583	0.00489	CcSEcCtD
Lacosamide—Nervous system disorder—Vemurafenib—skin cancer	0.00058	0.00486	CcSEcCtD
Lacosamide—Ataxia—Temozolomide—skin cancer	0.000578	0.00485	CcSEcCtD
Lacosamide—Skin disorder—Vemurafenib—skin cancer	0.000575	0.00482	CcSEcCtD
Lacosamide—Nausea—Vismodegib—skin cancer	0.000569	0.00477	CcSEcCtD
Lacosamide—Agitation—Imiquimod—skin cancer	0.000568	0.00476	CcSEcCtD
Lacosamide—Osteoarthritis—Fluorouracil—skin cancer	0.000567	0.00475	CcSEcCtD
Lacosamide—Angioedema—Imiquimod—skin cancer	0.000565	0.00474	CcSEcCtD
Lacosamide—Syncope—Imiquimod—skin cancer	0.000554	0.00465	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000554	0.00464	CcSEcCtD
Lacosamide—SCN10A—lymph node—skin cancer	0.000553	0.00953	CbGeAlD
Lacosamide—Neutropenia—Dactinomycin—skin cancer	0.00055	0.00461	CcSEcCtD
Lacosamide—Palpitations—Imiquimod—skin cancer	0.000546	0.00458	CcSEcCtD
Lacosamide—Loss of consciousness—Imiquimod—skin cancer	0.000543	0.00455	CcSEcCtD
Lacosamide—Irritability—Fluorouracil—skin cancer	0.000541	0.00454	CcSEcCtD
Lacosamide—Ataxia—Fluorouracil—skin cancer	0.000533	0.00447	CcSEcCtD
Lacosamide—CA2—lymphoid tissue—skin cancer	0.000527	0.00907	CbGeAlD
Lacosamide—Chest pain—Imiquimod—skin cancer	0.000526	0.00441	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000523	0.00438	CcSEcCtD
Lacosamide—Discomfort—Imiquimod—skin cancer	0.00052	0.00436	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00052	0.00436	CcSEcCtD
Lacosamide—CA5B—lymph node—skin cancer	0.000519	0.00894	CbGeAlD
Lacosamide—Dry mouth—Imiquimod—skin cancer	0.000515	0.00431	CcSEcCtD
Lacosamide—CA4—head—skin cancer	0.000512	0.00881	CbGeAlD
Lacosamide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000511	0.00428	CcSEcCtD
Lacosamide—Fatigue—Vemurafenib—skin cancer	0.00051	0.00428	CcSEcCtD
Lacosamide—CA2—female reproductive system—skin cancer	0.000508	0.00875	CbGeAlD
Lacosamide—Constipation—Vemurafenib—skin cancer	0.000506	0.00424	CcSEcCtD
Lacosamide—SCN3A—lymph node—skin cancer	0.000504	0.00869	CbGeAlD
Lacosamide—Hypoaesthesia—Bleomycin—skin cancer	0.000502	0.00421	CcSEcCtD
Lacosamide—Neutropenia—Temozolomide—skin cancer	0.000497	0.00417	CcSEcCtD
Lacosamide—Shock—Imiquimod—skin cancer	0.000496	0.00416	CcSEcCtD
Lacosamide—Nervous system disorder—Imiquimod—skin cancer	0.000495	0.00415	CcSEcCtD
Lacosamide—Skin disorder—Imiquimod—skin cancer	0.00049	0.00411	CcSEcCtD
Lacosamide—Agranulocytosis—Dactinomycin—skin cancer	0.000489	0.0041	CcSEcCtD
Lacosamide—Hyperhidrosis—Imiquimod—skin cancer	0.000488	0.00409	CcSEcCtD
Lacosamide—Eosinophilia—Fluorouracil—skin cancer	0.000485	0.00407	CcSEcCtD
Lacosamide—Depression—Temozolomide—skin cancer	0.000473	0.00396	CcSEcCtD
Lacosamide—Hepatitis—Dactinomycin—skin cancer	0.00047	0.00394	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00047	0.00394	CcSEcCtD
Lacosamide—Body temperature increased—Vemurafenib—skin cancer	0.000468	0.00392	CcSEcCtD
Lacosamide—CA1—lymph node—skin cancer	0.000458	0.00789	CbGeAlD
Lacosamide—Insomnia—Imiquimod—skin cancer	0.000456	0.00383	CcSEcCtD
Lacosamide—Paraesthesia—Imiquimod—skin cancer	0.000453	0.0038	CcSEcCtD
Lacosamide—Somnolence—Imiquimod—skin cancer	0.000448	0.00376	CcSEcCtD
Lacosamide—Hepatobiliary disease—Temozolomide—skin cancer	0.000448	0.00376	CcSEcCtD
Lacosamide—Erythema multiforme—Dactinomycin—skin cancer	0.000445	0.00373	CcSEcCtD
Lacosamide—Dyspepsia—Imiquimod—skin cancer	0.000444	0.00372	CcSEcCtD
Lacosamide—Erythema—Bleomycin—skin cancer	0.000439	0.00368	CcSEcCtD
Lacosamide—Hypersensitivity—Vemurafenib—skin cancer	0.000436	0.00365	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Imiquimod—skin cancer	0.000435	0.00365	CcSEcCtD
Lacosamide—Fatigue—Imiquimod—skin cancer	0.000435	0.00365	CcSEcCtD
Lacosamide—Atrial fibrillation—Docetaxel—skin cancer	0.000432	0.00362	CcSEcCtD
Lacosamide—Hepatitis—Temozolomide—skin cancer	0.000425	0.00357	CcSEcCtD
Lacosamide—Asthenia—Vemurafenib—skin cancer	0.000424	0.00356	CcSEcCtD
Lacosamide—CA2—head—skin cancer	0.000424	0.00731	CbGeAlD
Lacosamide—Hypoaesthesia—Temozolomide—skin cancer	0.000423	0.00355	CcSEcCtD
Lacosamide—Hallucination—Temozolomide—skin cancer	0.000423	0.00355	CcSEcCtD
Lacosamide—Pruritus—Vemurafenib—skin cancer	0.000418	0.00351	CcSEcCtD
Lacosamide—Connective tissue disorder—Temozolomide—skin cancer	0.000418	0.00351	CcSEcCtD
Lacosamide—Feeling abnormal—Imiquimod—skin cancer	0.000416	0.00349	CcSEcCtD
Lacosamide—Erythema—Dactinomycin—skin cancer	0.000409	0.00343	CcSEcCtD
Lacosamide—Agranulocytosis—Fluorouracil—skin cancer	0.000408	0.00342	CcSEcCtD
Lacosamide—Anaemia—Bleomycin—skin cancer	0.000406	0.0034	CcSEcCtD
Lacosamide—Diarrhoea—Vemurafenib—skin cancer	0.000405	0.00339	CcSEcCtD
Lacosamide—Erythema multiforme—Temozolomide—skin cancer	0.000402	0.00337	CcSEcCtD
Lacosamide—Urticaria—Imiquimod—skin cancer	0.000401	0.00336	CcSEcCtD
Lacosamide—Body temperature increased—Imiquimod—skin cancer	0.000399	0.00334	CcSEcCtD
Lacosamide—Eye disorder—Temozolomide—skin cancer	0.000398	0.00333	CcSEcCtD
Lacosamide—Tinnitus—Temozolomide—skin cancer	0.000397	0.00333	CcSEcCtD
Lacosamide—Cardiac disorder—Temozolomide—skin cancer	0.000395	0.00331	CcSEcCtD
Lacosamide—Dizziness—Vemurafenib—skin cancer	0.000391	0.00328	CcSEcCtD
Lacosamide—Hypoaesthesia—Fluorouracil—skin cancer	0.00039	0.00327	CcSEcCtD
Lacosamide—Ataxia—Docetaxel—skin cancer	0.000385	0.00322	CcSEcCtD
Lacosamide—Immune system disorder—Temozolomide—skin cancer	0.000384	0.00322	CcSEcCtD
Lacosamide—Anaemia—Dactinomycin—skin cancer	0.000378	0.00317	CcSEcCtD
Lacosamide—Liver function test abnormal—Docetaxel—skin cancer	0.000378	0.00317	CcSEcCtD
Lacosamide—Vomiting—Vemurafenib—skin cancer	0.000376	0.00315	CcSEcCtD
Lacosamide—Chest pain—Bleomycin—skin cancer	0.000374	0.00313	CcSEcCtD
Lacosamide—Rash—Vemurafenib—skin cancer	0.000373	0.00313	CcSEcCtD
Lacosamide—Mental disorder—Temozolomide—skin cancer	0.000373	0.00313	CcSEcCtD
Lacosamide—Dermatitis—Vemurafenib—skin cancer	0.000373	0.00312	CcSEcCtD
Lacosamide—Hypersensitivity—Imiquimod—skin cancer	0.000372	0.00312	CcSEcCtD
Lacosamide—Headache—Vemurafenib—skin cancer	0.000371	0.00311	CcSEcCtD
Lacosamide—Erythema—Temozolomide—skin cancer	0.00037	0.00311	CcSEcCtD
Lacosamide—Discomfort—Bleomycin—skin cancer	0.000369	0.0031	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000368	0.00309	CcSEcCtD
Lacosamide—Asthenia—Imiquimod—skin cancer	0.000362	0.00303	CcSEcCtD
Lacosamide—Confusional state—Bleomycin—skin cancer	0.000361	0.00303	CcSEcCtD
Lacosamide—CA4—lymph node—skin cancer	0.000358	0.00617	CbGeAlD
Lacosamide—Pruritus—Imiquimod—skin cancer	0.000357	0.00299	CcSEcCtD
Lacosamide—Nausea—Vemurafenib—skin cancer	0.000351	0.00295	CcSEcCtD
Lacosamide—Vision blurred—Temozolomide—skin cancer	0.000349	0.00293	CcSEcCtD
Lacosamide—Tremor—Temozolomide—skin cancer	0.000347	0.00291	CcSEcCtD
Lacosamide—Diarrhoea—Imiquimod—skin cancer	0.000345	0.00289	CcSEcCtD
Lacosamide—Discomfort—Dactinomycin—skin cancer	0.000344	0.00289	CcSEcCtD
Lacosamide—Anaemia—Temozolomide—skin cancer	0.000342	0.00287	CcSEcCtD
Lacosamide—Erythema—Fluorouracil—skin cancer	0.000341	0.00286	CcSEcCtD
Lacosamide—Agitation—Temozolomide—skin cancer	0.00034	0.00285	CcSEcCtD
Lacosamide—Angioedema—Temozolomide—skin cancer	0.000338	0.00284	CcSEcCtD
Lacosamide—Dizziness—Imiquimod—skin cancer	0.000334	0.0028	CcSEcCtD
Lacosamide—Vertigo—Temozolomide—skin cancer	0.000333	0.00279	CcSEcCtD
Lacosamide—Neutropenia—Docetaxel—skin cancer	0.000331	0.00277	CcSEcCtD
Lacosamide—Palpitations—Temozolomide—skin cancer	0.000327	0.00274	CcSEcCtD
Lacosamide—Paraesthesia—Bleomycin—skin cancer	0.000322	0.0027	CcSEcCtD
Lacosamide—Vision blurred—Fluorouracil—skin cancer	0.000322	0.0027	CcSEcCtD
Lacosamide—Vomiting—Imiquimod—skin cancer	0.000321	0.00269	CcSEcCtD
Lacosamide—Rash—Imiquimod—skin cancer	0.000318	0.00267	CcSEcCtD
Lacosamide—Dermatitis—Imiquimod—skin cancer	0.000318	0.00266	CcSEcCtD
Lacosamide—Headache—Imiquimod—skin cancer	0.000316	0.00265	CcSEcCtD
Lacosamide—Anaemia—Fluorouracil—skin cancer	0.000315	0.00264	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000313	0.00263	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000312	0.00262	CcSEcCtD
Lacosamide—Discomfort—Temozolomide—skin cancer	0.000312	0.00261	CcSEcCtD
Lacosamide—Dry mouth—Temozolomide—skin cancer	0.000308	0.00259	CcSEcCtD
Lacosamide—Confusional state—Temozolomide—skin cancer	0.000305	0.00256	CcSEcCtD
Lacosamide—Nausea—Imiquimod—skin cancer	0.0003	0.00251	CcSEcCtD
Lacosamide—Hepatobiliary disease—Docetaxel—skin cancer	0.000298	0.0025	CcSEcCtD
Lacosamide—CA2—lymph node—skin cancer	0.000297	0.00512	CbGeAlD
Lacosamide—Nervous system disorder—Temozolomide—skin cancer	0.000296	0.00249	CcSEcCtD
Lacosamide—Feeling abnormal—Bleomycin—skin cancer	0.000295	0.00248	CcSEcCtD
Lacosamide—Agranulocytosis—Docetaxel—skin cancer	0.000294	0.00247	CcSEcCtD
Lacosamide—Skin disorder—Temozolomide—skin cancer	0.000294	0.00246	CcSEcCtD
Lacosamide—Hyperhidrosis—Temozolomide—skin cancer	0.000292	0.00245	CcSEcCtD
Lacosamide—Chest pain—Fluorouracil—skin cancer	0.000291	0.00244	CcSEcCtD
Lacosamide—Fatigue—Dactinomycin—skin cancer	0.000288	0.00242	CcSEcCtD
Lacosamide—Discomfort—Fluorouracil—skin cancer	0.000287	0.00241	CcSEcCtD
Lacosamide—Urticaria—Bleomycin—skin cancer	0.000285	0.00239	CcSEcCtD
Lacosamide—Body temperature increased—Bleomycin—skin cancer	0.000283	0.00238	CcSEcCtD
Lacosamide—Hepatitis—Docetaxel—skin cancer	0.000283	0.00237	CcSEcCtD
Lacosamide—Hypoaesthesia—Docetaxel—skin cancer	0.000282	0.00236	CcSEcCtD
Lacosamide—Confusional state—Fluorouracil—skin cancer	0.000281	0.00235	CcSEcCtD
Lacosamide—Connective tissue disorder—Docetaxel—skin cancer	0.000278	0.00233	CcSEcCtD
Lacosamide—Feeling abnormal—Dactinomycin—skin cancer	0.000275	0.00231	CcSEcCtD
Lacosamide—Insomnia—Temozolomide—skin cancer	0.000273	0.00229	CcSEcCtD
Lacosamide—Nervous system disorder—Fluorouracil—skin cancer	0.000273	0.00229	CcSEcCtD
Lacosamide—Paraesthesia—Temozolomide—skin cancer	0.000271	0.00228	CcSEcCtD
Lacosamide—Somnolence—Temozolomide—skin cancer	0.000269	0.00225	CcSEcCtD
Lacosamide—Erythema multiforme—Docetaxel—skin cancer	0.000268	0.00224	CcSEcCtD
Lacosamide—Dyspepsia—Temozolomide—skin cancer	0.000266	0.00223	CcSEcCtD
Lacosamide—Eye disorder—Docetaxel—skin cancer	0.000264	0.00222	CcSEcCtD
Lacosamide—Body temperature increased—Dactinomycin—skin cancer	0.000264	0.00222	CcSEcCtD
Lacosamide—Hypersensitivity—Bleomycin—skin cancer	0.000264	0.00221	CcSEcCtD
Lacosamide—Cardiac disorder—Docetaxel—skin cancer	0.000263	0.0022	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000261	0.00219	CcSEcCtD
Lacosamide—Fatigue—Temozolomide—skin cancer	0.000261	0.00219	CcSEcCtD
Lacosamide—Constipation—Temozolomide—skin cancer	0.000258	0.00217	CcSEcCtD
Lacosamide—Asthenia—Bleomycin—skin cancer	0.000257	0.00216	CcSEcCtD
Lacosamide—Immune system disorder—Docetaxel—skin cancer	0.000256	0.00214	CcSEcCtD
Lacosamide—Pruritus—Bleomycin—skin cancer	0.000254	0.00213	CcSEcCtD
Lacosamide—Insomnia—Fluorouracil—skin cancer	0.000252	0.00211	CcSEcCtD
Lacosamide—Paraesthesia—Fluorouracil—skin cancer	0.00025	0.0021	CcSEcCtD
Lacosamide—Feeling abnormal—Temozolomide—skin cancer	0.000249	0.00209	CcSEcCtD
Lacosamide—Mental disorder—Docetaxel—skin cancer	0.000248	0.00208	CcSEcCtD
Lacosamide—Somnolence—Fluorouracil—skin cancer	0.000248	0.00208	CcSEcCtD
Lacosamide—Erythema—Docetaxel—skin cancer	0.000246	0.00207	CcSEcCtD
Lacosamide—Hypersensitivity—Dactinomycin—skin cancer	0.000246	0.00206	CcSEcCtD
Lacosamide—Dyspepsia—Fluorouracil—skin cancer	0.000245	0.00206	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00024	0.00202	CcSEcCtD
Lacosamide—Urticaria—Temozolomide—skin cancer	0.00024	0.00201	CcSEcCtD
Lacosamide—Asthenia—Dactinomycin—skin cancer	0.00024	0.00201	CcSEcCtD
Lacosamide—Body temperature increased—Temozolomide—skin cancer	0.000239	0.002	CcSEcCtD
Lacosamide—Muscle spasms—Docetaxel—skin cancer	0.000237	0.00199	CcSEcCtD
Lacosamide—Feeling abnormal—Fluorouracil—skin cancer	0.00023	0.00192	CcSEcCtD
Lacosamide—Diarrhoea—Dactinomycin—skin cancer	0.000229	0.00192	CcSEcCtD
Lacosamide—Vomiting—Bleomycin—skin cancer	0.000228	0.00191	CcSEcCtD
Lacosamide—Anaemia—Docetaxel—skin cancer	0.000228	0.00191	CcSEcCtD
Lacosamide—Rash—Bleomycin—skin cancer	0.000226	0.00189	CcSEcCtD
Lacosamide—Dermatitis—Bleomycin—skin cancer	0.000226	0.00189	CcSEcCtD
Lacosamide—Hypersensitivity—Temozolomide—skin cancer	0.000223	0.00187	CcSEcCtD
Lacosamide—Urticaria—Fluorouracil—skin cancer	0.000221	0.00186	CcSEcCtD
Lacosamide—Syncope—Docetaxel—skin cancer	0.000221	0.00185	CcSEcCtD
Lacosamide—Body temperature increased—Fluorouracil—skin cancer	0.00022	0.00185	CcSEcCtD
Lacosamide—Palpitations—Docetaxel—skin cancer	0.000218	0.00183	CcSEcCtD
Lacosamide—Asthenia—Temozolomide—skin cancer	0.000217	0.00182	CcSEcCtD
Lacosamide—Loss of consciousness—Docetaxel—skin cancer	0.000216	0.00182	CcSEcCtD
Lacosamide—Pruritus—Temozolomide—skin cancer	0.000214	0.00179	CcSEcCtD
Lacosamide—Nausea—Bleomycin—skin cancer	0.000213	0.00178	CcSEcCtD
Lacosamide—Vomiting—Dactinomycin—skin cancer	0.000212	0.00178	CcSEcCtD
Lacosamide—Rash—Dactinomycin—skin cancer	0.000211	0.00177	CcSEcCtD
Lacosamide—Chest pain—Docetaxel—skin cancer	0.00021	0.00176	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000208	0.00175	CcSEcCtD
Lacosamide—Diarrhoea—Temozolomide—skin cancer	0.000207	0.00173	CcSEcCtD
Lacosamide—Hypersensitivity—Fluorouracil—skin cancer	0.000205	0.00172	CcSEcCtD
Lacosamide—Dry mouth—Docetaxel—skin cancer	0.000205	0.00172	CcSEcCtD
Lacosamide—Confusional state—Docetaxel—skin cancer	0.000203	0.0017	CcSEcCtD
Lacosamide—Dizziness—Temozolomide—skin cancer	0.0002	0.00168	CcSEcCtD
Lacosamide—Nausea—Dactinomycin—skin cancer	0.000199	0.00166	CcSEcCtD
Lacosamide—Shock—Docetaxel—skin cancer	0.000198	0.00166	CcSEcCtD
Lacosamide—Nervous system disorder—Docetaxel—skin cancer	0.000197	0.00165	CcSEcCtD
Lacosamide—Pruritus—Fluorouracil—skin cancer	0.000197	0.00165	CcSEcCtD
Lacosamide—Skin disorder—Docetaxel—skin cancer	0.000195	0.00164	CcSEcCtD
Lacosamide—Vomiting—Temozolomide—skin cancer	0.000192	0.00161	CcSEcCtD
Lacosamide—Rash—Temozolomide—skin cancer	0.000191	0.0016	CcSEcCtD
Lacosamide—Diarrhoea—Fluorouracil—skin cancer	0.000191	0.0016	CcSEcCtD
Lacosamide—Dermatitis—Temozolomide—skin cancer	0.00019	0.0016	CcSEcCtD
Lacosamide—Headache—Temozolomide—skin cancer	0.000189	0.00159	CcSEcCtD
Lacosamide—Dizziness—Fluorouracil—skin cancer	0.000184	0.00154	CcSEcCtD
Lacosamide—Insomnia—Docetaxel—skin cancer	0.000182	0.00152	CcSEcCtD
Lacosamide—Paraesthesia—Docetaxel—skin cancer	0.000181	0.00151	CcSEcCtD
Lacosamide—Nausea—Temozolomide—skin cancer	0.00018	0.00151	CcSEcCtD
Lacosamide—Somnolence—Docetaxel—skin cancer	0.000179	0.0015	CcSEcCtD
Lacosamide—Vomiting—Fluorouracil—skin cancer	0.000177	0.00148	CcSEcCtD
Lacosamide—Dyspepsia—Docetaxel—skin cancer	0.000177	0.00148	CcSEcCtD
Lacosamide—Rash—Fluorouracil—skin cancer	0.000176	0.00147	CcSEcCtD
Lacosamide—Dermatitis—Fluorouracil—skin cancer	0.000175	0.00147	CcSEcCtD
Lacosamide—Headache—Fluorouracil—skin cancer	0.000174	0.00146	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000174	0.00146	CcSEcCtD
Lacosamide—Fatigue—Docetaxel—skin cancer	0.000173	0.00145	CcSEcCtD
Lacosamide—Constipation—Docetaxel—skin cancer	0.000172	0.00144	CcSEcCtD
Lacosamide—Feeling abnormal—Docetaxel—skin cancer	0.000166	0.00139	CcSEcCtD
Lacosamide—Nausea—Fluorouracil—skin cancer	0.000165	0.00139	CcSEcCtD
Lacosamide—Body temperature increased—Docetaxel—skin cancer	0.000159	0.00133	CcSEcCtD
Lacosamide—Hypersensitivity—Docetaxel—skin cancer	0.000148	0.00124	CcSEcCtD
Lacosamide—Asthenia—Docetaxel—skin cancer	0.000144	0.00121	CcSEcCtD
Lacosamide—Pruritus—Docetaxel—skin cancer	0.000142	0.00119	CcSEcCtD
Lacosamide—Diarrhoea—Docetaxel—skin cancer	0.000138	0.00115	CcSEcCtD
Lacosamide—Dizziness—Docetaxel—skin cancer	0.000133	0.00111	CcSEcCtD
Lacosamide—Vomiting—Docetaxel—skin cancer	0.000128	0.00107	CcSEcCtD
Lacosamide—Rash—Docetaxel—skin cancer	0.000127	0.00106	CcSEcCtD
Lacosamide—Dermatitis—Docetaxel—skin cancer	0.000127	0.00106	CcSEcCtD
Lacosamide—Headache—Docetaxel—skin cancer	0.000126	0.00106	CcSEcCtD
Lacosamide—Nausea—Docetaxel—skin cancer	0.000119	0.001	CcSEcCtD
